Nasser A. Dhayat
Hochfelden, ZH, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects.
Journal: Clinical kidney journal
Published: October 06, 2025
Deep biochemical phenotyping reveals prognostic value of rare genetic variants in adult kidney stone disease.
Journal: The Journal of clinical investigation
Published: June 09, 2025
Estimating 24-hour urine phosphate excretion from spot urine.
Journal: Clinical kidney journal
Published: December 09, 2024
Acid excretion is impaired in calcium oxalate stone formers.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 07, 2024
Hydrochlorothiazide and Bone Mineral Density in Patients with Kidney Stones: Post Hoc Analysis of the NOSTONE Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: September 23, 2024
Risk Factors of Asymptomatic Kidney Stone Passage in Adults with Recurrent Kidney Stones.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 30, 2023
The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
Journal: Kidney international reports
Published: October 18, 2023
Routine Urinary Biochemistry Does Not Accurately Predict Stone Type Nor Recurrence in Kidney Stone Formers: A Multicentre, Multimodel, Externally Validated Machine-Learning Study.
Journal: Journal of endourology
Published: October 13, 2023
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Journal: The New England journal of medicine
Published: March 01, 2023
The Swiss Kidney Stone Cohort: A Longitudinal, Multicentric, Observational Cohort to Study Course and Causes of Kidney Stone Disease in Switzerland.
Journal: Kidney & blood pressure research
Published: October 16, 2022
Tolvaptan treatment is associated with altered mineral metabolism parameters and increased bone mineral density in ADPKD patients.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 13, 2022
Life-course socioeconomic factors are associated with markers of epigenetic aging in a population-based study.
Journal: Psychoneuroendocrinology
Published: July 07, 2022
Last Updated: 09/26/2026